Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
ACS Synth Biol ; 13(8): 2457-2469, 2024 Aug 16.
Artículo en Inglés | MEDLINE | ID: mdl-39042380

RESUMEN

l-Homoserine is a promising C4 platform compound used in the agricultural, cosmetic, and pharmaceutical industries. Numerous works have been conducted to engineer Escherichia coli to be an excellent l-homoserine producer, but it is still unable to meet the industrial-scale demand. Herein, we successfully engineered a plasmid-free and noninducible E. coli strain with highly efficient l-homoserine production through balancing AspC and AspA synthesis pathways. First, an initial strain was constructed by increasing the accumulation of the precursor oxaloacetate and attenuating the organic acid synthesis pathway. To remodel the carbon flux toward l-aspartate, a balanced route prone to high yield based on TCA intensity regulation was designed. Subsequently, the main synthetic pathway and the cofactor system were strengthened to reinforce the l-homoserine synthesis. Ultimately, under two-stage DO control, strain HSY43 showed 125.07 g/L l-homoserine production in a 5 L fermenter in 60 h, with a yield of 0.62 g/g glucose and a productivity of 2.08 g/L/h. The titer, yield, and productivity surpassed the highest reported levels for plasmid-free strains in the literature. The strategies adopted in this study can be applied to the production of other l-aspartate family amino acids.


Asunto(s)
Escherichia coli , Homoserina , Ingeniería Metabólica , Escherichia coli/genética , Escherichia coli/metabolismo , Ingeniería Metabólica/métodos , Homoserina/metabolismo , Homoserina/análogos & derivados , Proteínas de Escherichia coli/genética , Proteínas de Escherichia coli/metabolismo , Ácido Aspártico/metabolismo , Fermentación , Plásmidos/genética , Plásmidos/metabolismo
2.
Molecules ; 26(23)2021 Nov 26.
Artículo en Inglés | MEDLINE | ID: mdl-34885764

RESUMEN

Lactate and isoprene are two common monomers for the industrial production of polyesters and synthetic rubbers. The present study tested the co-production of D-lactate and isoprene by engineered Escherichia coli in microaerobic conditions. The deletion of alcohol dehydrogenase (adhE) and acetate kinase (ackA) genes, along with the supplementation with betaine, improved the co-production of lactate and isoprene from the substrates of glucose and mevalonate. In fed-batch studies, microaerobic fermentation significantly improved the isoprene concentration in fermentation outlet gas (average 0.021 g/L), compared with fermentation under aerobic conditions (average 0.0009 g/L). The final production of D-lactate and isoprene can reach 44.0 g/L and 3.2 g/L, respectively, through fed-batch microaerobic fermentation. Our study demonstrated a dual-phase production strategy in the co-production of isoprene (gas phase) and lactate (liquid phase). The increased concentration of gas-phase isoprene could benefit the downstream process and decrease the production cost to collect and purify the bio-isoprene from the fermentation outlet gas. The proposed microaerobic process can potentially be applied in the production of other volatile bioproducts to benefit the downstream purification process.


Asunto(s)
Escherichia coli/genética , Hemiterpenos/biosíntesis , Ácido Láctico/biosíntesis , Ingeniería Metabólica , Aerobiosis/genética , Butadienos/química , Escherichia coli/metabolismo , Fermentación , Hemiterpenos/química , Ácido Láctico/química , Ácido Mevalónico/química
3.
Bioresour Technol ; 245(Pt A): 123-131, 2017 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-28892681

RESUMEN

Hydrogen yields of dark fermentation are limited due to the need to also produce reduced side products, and photofermentation, an alternative, is limited by the need for light. A relatively new strategy, dark microaerobic fermentation, could potentially overcome both these constraints. Here, application of this strategy demonstrated for the first time significant hydrogen production from lactate by a single organism in the dark. Response surface methodology (RSM) was used to optimize substrate and oxygen concentration as well as inoculum using both (1) regular batch and (2) O2 fed batch cultures. The highest hydrogen yield (HY) was observed under regular batch (1.4±0.1molH2/mollactate) and the highest hydrogen production (HP) (173.5µmolH2) was achieved using O2 fed batch. This study has provided proof of principal for the ability of microaerobic fermentation to drive thermodynamically difficult reactions, such as the conversion of lactate to hydrogen.


Asunto(s)
Hidrógeno , Ácido Láctico , Rhodopseudomonas , Técnicas de Cultivo Celular por Lotes , Fermentación
4.
Appl Microbiol Biotechnol ; 101(9): 3567-3575, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28168313

RESUMEN

The SPT15 gene encodes a Saccharomyces cerevisiae TATA-binding protein, which is able to globally control the transcription levels of various metabolic and regulatory genes. In this study, a SPT15 gene mutant (S42N, S78R, S163P, and I212N) was expressed in S. cerevisiae BY4741 (BSPT15-M3), of which effects on fermentative yeast properties were evaluated in a series of culture types. By applying different nitrogen sources and air supply conditions in batch culture, organic nitrogen sources and microaerobic condition were decided to be more favorable for both cell growth and ethanol production of the BSPT15-M3 strain than the control S. cerevisiae BY4741 strain expressing the SPT15 gene (BSPT15wt). Microaerobic fed-batch cultures of BSPT15-M3 with glucose shock in the presence of high ethanol content resulted in a 9.5-13.4% higher glucose consumption rate and ethanol productivity than those for the BSPT15wt strain. In addition, BSPT15-M3 showed 4.5 and 3.9% increases in ethanol productivity from cassava hydrolysates and corn starch in simultaneous saccharification and fermentation processes, respectively. It was concluded that overexpression of the mutated SPT15 gene would be a potent strategy to develop robust S. cerevisiae strains with enhanced cell growth and ethanol production abilities.


Asunto(s)
Etanol/metabolismo , Expresión Génica , Ingeniería Metabólica , Proteínas de Saccharomyces cerevisiae/metabolismo , Saccharomyces cerevisiae/crecimiento & desarrollo , Saccharomyces cerevisiae/metabolismo , Proteína de Unión a TATA-Box/metabolismo , Aerobiosis , Anaerobiosis , Medios de Cultivo/química , Fermentación , Manihot/metabolismo , Proteínas Mutantes/genética , Proteínas Mutantes/metabolismo , Nitrógeno/metabolismo , Saccharomyces cerevisiae/genética , Proteínas de Saccharomyces cerevisiae/genética , Almidón/metabolismo , Proteína de Unión a TATA-Box/genética , Zea mays/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA